Canada markets close in 6 hours 13 minutes

Korea Arlico Pharm Co.,Ltd. (260660.KQ)

KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
Add to watchlist
4,860.000.00 (0.00%)
At close: 03:30PM KST
Currency in KRW

Valuation Measures4

Market Cap (intraday) 72.97B
Enterprise Value 94.50B
Trailing P/E 12.77
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.40
Price/Book (mrq)0.86
Enterprise Value/Revenue 0.51
Enterprise Value/EBITDA 16.03

Trading Information

Stock Price History

Beta (5Y Monthly) 0.88
52-Week Change 3-19.40%
S&P500 52-Week Change 324.96%
52 Week High 37,480.00
52 Week Low 34,830.00
50-Day Moving Average 35,016.40
200-Day Moving Average 35,560.25

Share Statistics

Avg Vol (3 month) 317.21k
Avg Vol (10 day) 341.55k
Shares Outstanding 515.01M
Implied Shares Outstanding 615.11M
Float 89M
% Held by Insiders 140.13%
% Held by Institutions 10.10%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4130
Forward Annual Dividend Yield 42.67%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4125.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 27, 2023
Last Split Factor 21.5:1
Last Split Date 3Jun 15, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -0.74%
Operating Margin (ttm)-3.47%

Management Effectiveness

Return on Assets (ttm)-0.57%
Return on Equity (ttm)-1.57%

Income Statement

Revenue (ttm)183.96B
Revenue Per Share (ttm)12,257.49
Quarterly Revenue Growth (yoy)-6.70%
Gross Profit (ttm)N/A
EBITDA 3.91B
Net Income Avi to Common (ttm)-1.37B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.38B
Total Cash Per Share (mrq)1,690.34
Total Debt (mrq)46.91B
Total Debt/Equity (mrq)54.99%
Current Ratio (mrq)1.13
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)2.07B
Levered Free Cash Flow (ttm)-18.6B